Source comparison
5. Frequency — weekly vs twice-weekly
TB-500 is commonly dosed less frequently than BPC-157: Weekly — most common in tissue-repair protocols Twice-weekly — used in more acute research models or when higher sustained exposure is the design goal Daily — less common; when used, typically at lower per
This comparison does not assign a generated winner or score.
- TB-500 is commonly dosed less frequently than BPC-157:
- Weekly — most common in tissue-repair protocols
- Twice-weekly — used in more acute research models or when higher sustained exposure is the design goal
- Daily — less common; when used, typically at lower per-dose amounts
- The less-frequent dosing reflects TB-500’s apparently longer half-life relative to BPC-157. However, rigorous comparative PK data between the two peptides are limited.